Company: SUPN
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001356576-25-000033
Chunk: 47

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
 $5,897 Stock Option The following table summarizes stock option activities:Number ofOptionsWeighted AverageExercise PriceWeightedAverageRemainingContractualTerm (in years)Outstanding, December 31, 20246,719,073 $30.44 5.9Granted 1,057,275 $33.86 Exercised (95,182)$21.46 Forfeited (31,924)$31.72 Outstanding, March 31, 2025 (unaudited)7,649,242 $31.01 6.3As of March 31, 2025 (unaudited):Vested and expected to vest7,649,242 $31.01 6.3Exercisable 4,893,002 $30.13 4.8As of December 31, 2024:Vested and expected to vest6,719,073 $30.44 5.9Exercisable4,137,283 $29.54 4.4Restricted Stock UnitsThe following table summarizes restricted stock unit (RSU) activities:Number ofRSUsWeighted AverageGrant Date Fair Value per ShareNonvested, December 31, 2024378,165 $32.48 Granted169,775 $33.52 Vested(136,673)$32.33 Forfeited(3,400)$32.17 Nonvested, March 31, 2025 (unaudited)407,867 $32.97 Performance Share Units 

15

The following table summarizes performance share unit (PSU) activities:Performance-Based UnitsMarket-Based UnitsTotal PSUs Number of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNonvested, December 31, 2024324,685 $28.80 20,000 $28.63 344,685 $28.79 Granted— $— — $— — $— Vested(111,065)$30.52 — $— (111,065)$30.52 Forfeited(35,900)$30.26 — $— (35,900)$30.26 Nonvested, March 31,